跳到正文
原文
Endpoints News 生物医药· Shelby Livingston·· 22 天前AI 评分40

HHS以“安全”和“自由”为由,将允许部分健康用途肽类的配制

Citing 'safety' and 'freedom,' HHS will allow compounding of certain wellness peptides

AI 导读

HHS周三表示,将停止执行对某些热门健康用途肽类配制的禁令,理由涉及“安全”和“自由”。该决定是在FDA继续处理相关事务期间作出的。

正文

HHS on Wednes­day said it will stop en­forc­ing a ban on the com­pound­ing of cer­tain pop­u­lar pep­tides used for well­ness pur­pos­es while the FDA works …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news